Solvay (SOLB) Q4 2025 earnings summary

Executive summary

• Delivered strong free cash flow of €350 million in 2025 despite a challenging environment, supported by operational excellence, robust cost savings, and disciplined cash allocation.

• Transformation initiatives included safety culture improvements, digitalization, sustainability progress, and industrial footprint optimization, with €101 million in cost savings in 2025 and cumulative savings of €211 million.

• Major restructuring actions included closure and capacity reduction at several European sites, ongoing fluorine business restructuring, and digitalization projects.

• Continued investment in strategic growth areas such as rare earths, biosourced silica, and hydrogen peroxide capacity expansion.

• Sustainability roadmap advanced, with Scope 1 & 2 CO2eq emissions reduced by 29% since 2021 and increased diversity in management.

Financial highlights

• Underlying net sales for 2025 were €4.3 billion, down 6–9% year-over-year, mainly due to lower volumes and pricing in Soda Ash and Coatis, and negative forex impact.

• Underlying EBITDA was €881 million, down 13–16.3% from 2024, with a margin of 20.7%.

• Free cash flow reached €350 million, aided by disciplined capex (€292 million) and strong working capital management.

• Net debt stood at €1.6 billion with a leverage ratio of 1.8x.

• Proposed total gross dividend of €2.43 per share, subject to shareholder approval.

Outlook and guidance

• 2026 underlying EBITDA expected between €770 million and €850 million, including €40 million in transformation expenses and €20 million negative currency impact.

• Free cash flow to shareholders projected to exceed €200 million after €90 million in transformation costs, with capex capped at €300 million.

• Cumulative structural cost savings targeted at €300 million by end of 2026.

• No significant recovery expected in Soda Ash or Coatis in 2026; other businesses remain resilient.

• Commitment to stable-to-increasing dividend and investment-grade rating reaffirmed.